Dan Liljenquist,former lawyer and state senator in Utah, now Director of Special Projects at Intermountain Healthcare, and Dr. Erin Fox,professor and expert on drug shortages at University of Utah, discuss a fresh initiative spearheaded by Intermountain Healthcare to create a non-profit that produces its own generic drugs. Several major not-for-profit hospitals are part of this initiative to stymie drug shortages and the high prices that reach with them. Intermountain Healthcare plans to either contract manufacturing to an existing pharmaceutical company or pick up the Food and Drug Administration approval to manufacture medication itself. By cutting out the intermediary, and these hospitals intend to wrest control of drug availability and pricing from the hands of the free-market,thereby offering patients more affordable and reliable care.
This segment is guest hosted by Rebecca Carroll.
Source: thetakeaway.org